Published trials of TACE for HCC are often not registered and subject to outcome reporting bias.

Grégory, Jules; Créquit, Perrine; Vilgrain, Valérie; Boutron, Isabelle; Ronot, Maxime

Grégory, Jules; Créquit, Perrine; Vilgrain, Valérie; Boutron, Isabelle; Ronot, Maxime.

Afiliación

Grégory J; INSERM, UMR1153, Epidemiology and Biostatistics Sorbonne Paris Cité Center (CRESS), METHODS team, Hôpital Hôtel Dieu, Paris, France.
Créquit P; Université de Paris, Paris, France.
Vilgrain V; Department of Radiology, Beaujon Hospital, Paris Nord Val de Seine Hospitals, Assistance Publique des Hôpitaux de Paris, Clichy, France.
Boutron I; INSERM, UMR1153, Epidemiology and Biostatistics Sorbonne Paris Cité Center (CRESS), METHODS team, Hôpital Hôtel Dieu, Paris, France.
Ronot M; Direction of Clinical Research, Foch Hospital, Suresnes, France.

JHEP Rep ; 3(1): 100196, 2021 Feb.

Article en En | MEDLINE | ID: mdl-33490934

Palabras clave

Bias; CENTRAL, Cochrane Central Register of Controlled Trials; ChiCTR, Chinese Clinical Trial Registry; Embolisation; HCC, hepatocellular carcinoma; Hepatocellular carcinoma; ICMJE, International Committee of Medical Journal Editors; ICTRP, International Clinical Trials Registry Platform; PO, primary outcome; Primary outcome; RCTs, randomised controlled trials; Randomised controlled trial; Registration; TACE, transarterial chemoembolisation; UMIN-CTR, University Hospital Medical Information Network Clinical Trials registry

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Clinical_trials / Guideline / Systematic_reviews Idioma: En Revista: JHEP Rep Año: 2021 Tipo del documento: Article País de afiliación: Francia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google